John C Cooper

Title: John C. Cooper – Innovator in Sialic Acid Binding Polypeptide

Introduction

John C. Cooper, based in Brooklyn, NY, is a notable inventor in the field of biochemistry, with a focus on sialic acid-binding polypeptides. His innovation has potential applications in various medical and diagnostic areas. He holds a single patent that highlights his expertise and contribution to science.

Latest Patents

John C. Cooper is credited with the patent for "Sialic acid binding polypeptide." This invention describes sialic acid recognizing-affinity reagents engineered from the neuraminidase NanB, showcasing lectin-like properties and defined specificities for sialic acid. This groundbreaking work serves as a significant contribution to the development of diagnostics and therapeutics in glycoscience.

Career Highlights

Cooper has worked with distinguished organizations, such as the University of Georgia Research Foundation, Inc. and Glycosensors and Diagnostics, LLC. His involvement in these institutions has allowed him to further his research and refine his innovative ideas, contributing to advancements in the field.

Collaborations

Throughout his career, John C. Cooper has collaborated with talented individuals like Loretta Yang and Kausar N. Samli. These collaborations have enabled the exchange of ideas and expertise, fostering an environment ripe for innovation and discovery in their respective fields.

Conclusion

John C. Cooper exemplifies the spirit of innovation within the scientific community. His research on sialic acid binding polypeptides marks a meaningful step in biochemistry, reflecting his dedication and contributions to advancements in modern science. As he continues to work with various institutions and collaborators, the potential impact of his inventions on medicine and diagnostics remains promising.